IPO Prospectus Preparation: HKSI Paper 16
Preparing a prospectus requires accurate, complete and balanced disclosure that gives investors a basis to assess the applicant and securities.
- The sponsor representative contributes through due diligence, coordination and verification, while the applicant and directors retain their responsibilities.
| Document area | Evidence and review focus |
|---|---|
| Business description | Operations, customers, suppliers and material contracts |
| Risk factors | Specific risks and appropriate significance |
| Financial information | Consistency, periods, units and reconciliation |
| MD&A | Causes, trends, liquidity and capital resources |
Organize drafting around the business model, history, operations, risks, financial information, use of proceeds, governance and material contracts. Ensure claims about market position, customers and projections have evidence. Unfavourable facts must receive appropriate significance, not be buried in boilerplate.
Coordinate consistency across sections, financial tables and expert reports. Check defined terms, dates, units, segment figures and cross-references. Material changes during the IPO process should trigger review of affected disclosure and regulator communications.
A clear prospectus is specific and balanced. Promotional language unsupported by evidence can mislead even when the numbers are correct.
A useful review sequence is to identify the statement, decide what evidence is needed, test it, resolve or escalate inconsistencies, and assess the effect on the listing document or ongoing obligations. The order may change with the facts, but the sponsor needs a reasoned basis for its conclusion.
Check the prospectus as a whole
Begin the document outline with the investor’s questions: what does the applicant do, how does it earn money, what assets and contracts matter, what can go wrong, how has it performed, and how will proceeds be used? Organize disclosure so answers can be found and cross-checked. Concision is useful only if it preserves material context.
Risk factors should connect to facts and consequences. Explain the source of risk, the exposure and possible effect. A generic sentence about competition may not describe customer concentration, changing regulation or dependence on one supplier. Ensure the section is balanced and does not bury specific adverse information in a long list.
Check use-of-proceeds and offering details against board approvals, underwriting and allocation mechanics. Confirm that amounts, purposes, timing and dependencies remain current. If proceeds may be redirected or a deal structure changes, update disclosure and assess whether regulator communication is needed.
Review consistency between the summary and detailed sections. The summary can simplify but must not overstate the business or omit a material qualification. Compare definitions, share numbers, dates and risk descriptions. An inconsistency can mislead even when each section was drafted by a different adviser.
Additional Paper 16 guidance
Create a prospectus index linking each section to evidence and an owner. This helps the team see which matters remain open and whether an expert or company response addresses the actual disclosure. Track new risks and data through versions, and review whether one section changes another section’s meaning.
The business section should describe the actual operating model and dependencies. Explain major customers, suppliers, products, channels, licenses and technology. Use evidence for market claims and avoid unsupported superlatives. Risk factors should identify the risk and potential effect rather than copy broad language used by many issuers.
Financial information and MD&A should connect. Explain drivers of revenue, expenses, margins and cash flow. Use consistent period labels and reconcile figures to source statements. If exceptional items or recent changes affect a trend, describe them and their effect on comparability.
Common questions
Who is responsible for prospectus disclosure?
The sponsor has its regulatory responsibilities, while the applicant and directors retain their own responsibilities. The sponsor’s review does not transfer those duties.
What makes disclosure balanced?
It explains material facts fairly, gives appropriate significance to adverse information and avoids promotional claims that lack evidence.
How should late changes be handled?
Assess which sections, financial tables and supporting evidence are affected, update verification and consider any required regulator communication.